Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001362155-26-000002

SVP, General Counsel sold 22,900 shares at $1.76 ($40,304)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Douglas Earl Martin SVP, General Counsel 2026-02-02 Sale −22,900 $1.76 $40,304 564,948 D
Derivatives
Douglas Earl Martin SVP, General Counsel 2026-02-02 Grant or award · Stock Option (Right to buy) +539,072 539,072 D
Douglas Earl Martin SVP, General Counsel 2026-02-02 Grant or award · Restricted Stock Unit +152,480 152,480 D
Open-market sales · 22,900 sh · avg $1.76 · $40,304
Loading xslF345X05/wk-form4_1770243135.xml…